CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 340 enrolled
Drug / intervention
noninvasive high-frequency ventilation (nHFOV) +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03099694
NCT03099694N/ACompleted

Noninvasive Ventilation for Preterm Neonates With Respiratory Distress Syndrome: a Multi-center Randomized Controlled Trial

Xingwang Zhu·interventional·Posted Apr 4, 2017·Updated Mar 2, 2021

In Brief

A clinical study evaluating noninvasive high-frequency ventilation (nHFOV) and nasal continuous positive airway pressure (nCPAP) for Preterm Infants. Completed, enrolled 340 participants across 1 site.

Detailed Summary

The investigators compared advantages and disadvantages of two forms of noninvasive respiratory support -noninvasive high-frequency oscillatory ventilation (nHFOV) or nasal continuous positive airway pressure (nCPAP) -as a primary mode of ventilation in premature infants with RDS.

Study Details

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 4, 2017
Enrollment StartApr 27, 2017
Primary CompletionJul 28, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.2 years ago

Interventions

noninvasive high-frequency ventilation (nHFOV)procedure

NHFOV will be provided by a high frequency ventilator (CNO, Medin, Germany or SLE 5000, UK). NHFOV will be provided via binasal prongs.

nasal continuous positive airway pressure (nCPAP)procedure

Infants assigned to the NCPAP group will be started on a pressure of 6 cmH2O (range: 6-8 cmH2O) by CPAP system (CNO Medin, Germany, Carefusion, USA)